La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter

Identifieur interne : 001368 ( PascalFrancis/Checkpoint ); précédent : 001367; suivant : 001369

Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter

Auteurs : E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France]

Source :

RBID : Pascal:99-0219067

Descripteurs français

English descriptors

Abstract

MPTP has been shown to induce parkinsonism both in human and in nonhuman primates. The precise mechanism of dopaminergic cell death induced following MPTP treatment is still subject to intense debate. MPP+, which is the oxidation product of MPTP, is actively transported into presynaptic dopaminergic nerve terminals through the plasma membrane dopamine transporter (DAT). In this study, we used mice lacking the DAT by homologous recombination and demonstrated that the MPTP-induced dopaminergic cell loss is dependent on the presence of the DAT. For this we have used tyrosine hydroxylase immunoreactivity (TH-IR) labeling of dopamine cells of the substantia nigra compacta in wild-type, heterozygote, and homozygote mice that were given either saline or MPTP treatments (two ip injections of 30 mg/kg, 10 h apart). Our results show a significant loss of TH-IR in wild type (34.4%), less loss in heterozygotes (22.5%), and no loss in homozygote animals. Thus dopamine cell loss is related to levels of the DAT. These results shed light on the degenerative process of dopamine neurons and suggest that individual differences in developing Parkinson's disease in human may be related to differences of uptake through the DAT of a yet unidentified neurotoxin.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:99-0219067

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter</title>
<author>
<name sortKey="Bezard, E" sort="Bezard, E" uniqKey="Bezard E" first="E." last="Bezard">E. Bezard</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gross, C E" sort="Gross, C E" uniqKey="Gross C" first="C. E." last="Gross">C. E. Gross</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fournier, M C" sort="Fournier, M C" uniqKey="Fournier M" first="M.-C." last="Fournier">M.-C. Fournier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>CNRS UMR 5541, Université de Bordeaux II, 146 rue Leo Saignat</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dovero, S" sort="Dovero, S" uniqKey="Dovero S" first="S." last="Dovero">S. Dovero</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bloch, B" sort="Bloch, B" uniqKey="Bloch B" first="B." last="Bloch">B. Bloch</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>CNRS UMR 5541, Université de Bordeaux II, 146 rue Leo Saignat</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jaber, M" sort="Jaber, M" uniqKey="Jaber M" first="M." last="Jaber">M. Jaber</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>CNRS UMR 5541, Université de Bordeaux II, 146 rue Leo Saignat</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">99-0219067</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0219067 INIST</idno>
<idno type="RBID">Pascal:99-0219067</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001512</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001B33</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001368</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001368</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter</title>
<author>
<name sortKey="Bezard, E" sort="Bezard, E" uniqKey="Bezard E" first="E." last="Bezard">E. Bezard</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gross, C E" sort="Gross, C E" uniqKey="Gross C" first="C. E." last="Gross">C. E. Gross</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fournier, M C" sort="Fournier, M C" uniqKey="Fournier M" first="M.-C." last="Fournier">M.-C. Fournier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>CNRS UMR 5541, Université de Bordeaux II, 146 rue Leo Saignat</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dovero, S" sort="Dovero, S" uniqKey="Dovero S" first="S." last="Dovero">S. Dovero</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bloch, B" sort="Bloch, B" uniqKey="Bloch B" first="B." last="Bloch">B. Bloch</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>CNRS UMR 5541, Université de Bordeaux II, 146 rue Leo Saignat</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jaber, M" sort="Jaber, M" uniqKey="Jaber M" first="M." last="Jaber">M. Jaber</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>CNRS UMR 5541, Université de Bordeaux II, 146 rue Leo Saignat</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Experimental neurology</title>
<title level="j" type="abbreviated">Exp. neurol.</title>
<idno type="ISSN">0014-4886</idno>
<imprint>
<date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Experimental neurology</title>
<title level="j" type="abbreviated">Exp. neurol.</title>
<idno type="ISSN">0014-4886</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>Animal model</term>
<term>Biological transport</term>
<term>Cell death</term>
<term>Conveyor</term>
<term>Deficiency</term>
<term>Dopamine</term>
<term>Dopaminergic neuron</term>
<term>Mouse</term>
<term>Neurotoxin</term>
<term>Parkinson disease</term>
<term>Pathogenesis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Déficit</term>
<term>Transporteur</term>
<term>Dopamine</term>
<term>Transport biologique</term>
<term>Parkinson maladie</term>
<term>Neurone dopaminergique</term>
<term>Neurotoxine</term>
<term>Pyridine(1-méthyl-4-phényl-1,2,3,6-tétrahydro)</term>
<term>Pathogénie</term>
<term>Modèle animal</term>
<term>Animal</term>
<term>Souris</term>
<term>Mort cellulaire</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Déficit</term>
<term>Transporteur</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">MPTP has been shown to induce parkinsonism both in human and in nonhuman primates. The precise mechanism of dopaminergic cell death induced following MPTP treatment is still subject to intense debate. MPP
<sup>+</sup>
, which is the oxidation product of MPTP, is actively transported into presynaptic dopaminergic nerve terminals through the plasma membrane dopamine transporter (DAT). In this study, we used mice lacking the DAT by homologous recombination and demonstrated that the MPTP-induced dopaminergic cell loss is dependent on the presence of the DAT. For this we have used tyrosine hydroxylase immunoreactivity (TH-IR) labeling of dopamine cells of the substantia nigra compacta in wild-type, heterozygote, and homozygote mice that were given either saline or MPTP treatments (two ip injections of 30 mg/kg, 10 h apart). Our results show a significant loss of TH-IR in wild type (34.4%), less loss in heterozygotes (22.5%), and no loss in homozygote animals. Thus dopamine cell loss is related to levels of the DAT. These results shed light on the degenerative process of dopamine neurons and suggest that individual differences in developing Parkinson's disease in human may be related to differences of uptake through the DAT of a yet unidentified neurotoxin.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0014-4886</s0>
</fA01>
<fA02 i1="01">
<s0>EXNEAC</s0>
</fA02>
<fA03 i2="1">
<s0>Exp. neurol.</s0>
</fA03>
<fA05>
<s2>155</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>BEZARD (E.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>GROSS (C. E.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>FOURNIER (M.-C.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>DOVERO (S.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>BLOCH (B.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>JABER (M.)</s1>
</fA11>
<fA14 i1="01">
<s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>CNRS UMR 5541, Université de Bordeaux II, 146 rue Leo Saignat</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA20>
<s1>268-273</s1>
</fA20>
<fA21>
<s1>1999</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>9181</s2>
<s5>354000073981760110</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>99-0219067</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Experimental neurology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>MPTP has been shown to induce parkinsonism both in human and in nonhuman primates. The precise mechanism of dopaminergic cell death induced following MPTP treatment is still subject to intense debate. MPP
<sup>+</sup>
, which is the oxidation product of MPTP, is actively transported into presynaptic dopaminergic nerve terminals through the plasma membrane dopamine transporter (DAT). In this study, we used mice lacking the DAT by homologous recombination and demonstrated that the MPTP-induced dopaminergic cell loss is dependent on the presence of the DAT. For this we have used tyrosine hydroxylase immunoreactivity (TH-IR) labeling of dopamine cells of the substantia nigra compacta in wild-type, heterozygote, and homozygote mice that were given either saline or MPTP treatments (two ip injections of 30 mg/kg, 10 h apart). Our results show a significant loss of TH-IR in wild type (34.4%), less loss in heterozygotes (22.5%), and no loss in homozygote animals. Thus dopamine cell loss is related to levels of the DAT. These results shed light on the degenerative process of dopamine neurons and suggest that individual differences in developing Parkinson's disease in human may be related to differences of uptake through the DAT of a yet unidentified neurotoxin.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Déficit</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Deficiency</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Déficiencia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Transporteur</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Conveyor</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Transportador</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Transport biologique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Biological transport</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Transporte biológico</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Neurone dopaminergique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Dopaminergic neuron</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Neurona dopaminérgica</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Neurotoxine</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Neurotoxin</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Neurotoxina</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Pyridine(1-méthyl-4-phényl-1,2,3,6-tétrahydro)</s0>
<s2>NK</s2>
<s2>FX</s2>
<s5>16</s5>
<s6>Pyridine(«1»-méthyl-«4»-phényl-«1,2,3,6»-tétrahydro)</s6>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Pathogénie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Pathogenesis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Patogenia</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Modèle animal</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Animal model</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Modelo animal</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Souris</s0>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Mouse</s0>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Ratón</s0>
<s5>21</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Mort cellulaire</s0>
<s5>23</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Cell death</s0>
<s5>23</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Muerte celular</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Catécholamine</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Catecholamine</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Catecolamina</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>53</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>54</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>54</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>55</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>55</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>55</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>56</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>56</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>56</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>57</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>57</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>57</s5>
</fC07>
<fN21>
<s1>137</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Aquitaine</li>
<li>Nouvelle-Aquitaine</li>
</region>
<settlement>
<li>Bordeaux</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Nouvelle-Aquitaine">
<name sortKey="Bezard, E" sort="Bezard, E" uniqKey="Bezard E" first="E." last="Bezard">E. Bezard</name>
</region>
<name sortKey="Bloch, B" sort="Bloch, B" uniqKey="Bloch B" first="B." last="Bloch">B. Bloch</name>
<name sortKey="Dovero, S" sort="Dovero, S" uniqKey="Dovero S" first="S." last="Dovero">S. Dovero</name>
<name sortKey="Fournier, M C" sort="Fournier, M C" uniqKey="Fournier M" first="M.-C." last="Fournier">M.-C. Fournier</name>
<name sortKey="Gross, C E" sort="Gross, C E" uniqKey="Gross C" first="C. E." last="Gross">C. E. Gross</name>
<name sortKey="Jaber, M" sort="Jaber, M" uniqKey="Jaber M" first="M." last="Jaber">M. Jaber</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001368 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001368 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:99-0219067
   |texte=   Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024